In addition, representative genes were evaluated using immunohistochemistry in clinical specimens, and in BLCA cell lines, functional experiments were performed to determine the biological behavior of hub gene PLOD1. The gene discussed is PLOD1; the disease is bladder transitional cell carcinoma.